How the FSH Society drives FSHD therapy development

This infographic from our FY2017 Donor Report illustrates how the FSH Society is involved at every stage of the treatment development process. We invest strategically at key stages along the entire trajectory. We invest where we see the need, to move us faster and most efficiently—from fundamental research on disease mechanisms and drug targets all the way to preclinical and clinical validation of new therapies.


Leave a Reply

Your email address will not be published. Required fields are marked *